General Information of the Compound
Compound ID
CP0522493
Compound Name
2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
    Show/Hide
Synonyms
2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
CHEMBL179168
SCHEMBL3540143
    Show/Hide
Structure
Formula
C16H15N3OS
Molecular Weight
297.383
Canonical SMILES
O=c1cc(nc2c3ccccc3ccn12)N1CCSCC1
    Show/Hide
InChI
InChI=1S/C16H15N3OS/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2
    Show/Hide
InChIKey
LGFZVFQIQUWUBJ-UHFFFAOYSA-N
Physicochemical Property
logP
2.4009
Rotatable Bonds
1
Heavy Atom Count
21
Polar Areas
37.61
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11289486
SID: 16376955
ChEMBL ID
CHEMBL179168
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00955, DNA-dependent protein kinase catalytic subunit
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 1690 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one )
Drug Name 2-Thiomorpholin-4-yl-pyrido[1,2-a]pyrimidin-4-one
Target(s)
DNA-dependent protein kinase catalytic (PRKDC)
Inhibitor